Results 91 to 100 of about 9,019 (158)

Efficacy of finerenone in reducing proteinuria in diabetic kidney disease with maximum tolerable doses of dapagliflozin and telmisartan. [PDF]

World J Nephrol
Pasari AS, Gupta S, Gurjar P, Ramteke V, Malde S, Pawar T, Jeyachandran V, Kashiv P, Dubey S, Kurundwadkar M, Sejpal K, Bawankule C, Deshpande N, Balwani MR.   +13 more
europepmc   +1 more source

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia. [PDF]

Clin Cardiol
Asim R, Muhammad TS, Ahmed S, Khurram L, Azeem B, Doggar ME, Muhammad AN, Chikatimalla R, Kapaganti S, Chigurupati HD, Qureshi B, Sandhyavenu H, Neppala S.   +12 more
europepmc   +1 more source

Evaluation of Effectiveness and Safety of Telmisartan and Amlodipine Fixed-Dose Combination in Indian Patients with Hypertension: TACT-India Study. [PDF]

Drugs Real World Outcomes
Das AK, Tiwaskar M, Abdullakutty J, Pande A, Kumar V, Francis F, Zalte N, Sugumaran A, Sawant S, Mohanasundaram S.   +9 more
europepmc   +1 more source

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine. [PDF]

Cureus
Hiremath J, Kirpalani A, Chafekar D, Jayagopal PB, Ray S, Chopra VK, Dani S, Tripathi K, Sawhney JPS, Oomman A, Sathe S, Abdullakutty J, Kher V, Dewan D, Sharma K, Shete M, Vali PS, Jain S, Swami OC.   +18 more
europepmc   +1 more source

Attenuation of cerebral ischemia-reperfusion induced neurotoxicity by telmisartan, ertugliflozin, and omaveloxolone through Nrf2/HO-1 pathway modulation: In vivo and in silico insights. [PDF]

Toxicol Rep
Alyassery YJH, Bairam AF, Martin CM.
europepmc   +1 more source

Effects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells. [PDF]

Int J Mol Sci
Delforce SJ, Mohammed R, Symington TL, Wang Y, Verrills NM, Lumbers ER, Pringle KG.   +6 more
europepmc   +1 more source

From design space to green space: an analytical quality by design-assisted high-performance liquid chromatography method for the quantification of triple-combination antihypertensive drugs. [PDF]

BMC Chem
Yenduri S, Yogaraj P, Koppuravuri NP.
europepmc   +1 more source

A Retrospective Analysis of Human Angiotensin II Receptor Blockers (ARB) Pharmacokinetics, Dosages and C_max Values for the Experimental Modelling of Pleiotropic and Supratherapeutic Activities. [PDF]

Basic Clin Pharmacol Toxicol
Evans A, Bernatchez P.
europepmc   +1 more source

Safety and efficacy of triple combination therapy in hypertension and dyslipidemia: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Egypt Heart J
Shaban AY, Hassan A, Eltawansy S, Hassan MA, Desouki MT, Ahmed N, Badr S, Elgendy AY, Nassar M, Hakim D.   +9 more
europepmc   +1 more source

Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Gong Z, Huang L, Long X, Zhang Y.
europepmc   +1 more source